UTILISATION DE BOULONS A LA RESINE DANS DEUX TUNNELS ROUTIERSPEDUZZI R; DELFORGE A.1979; TUNNELS OUVR. SOUTERR.; FRA; DA. 1979; NO 31; PP. 38-45; ABS. ENG/GERArticle

SUPPRESSION DE LA POLLUTION PROVOQUEE PAR LE LAVAGE DE LA LAINE, GRACE AU PROCEDE SOVERBRACH J; DELFORGE A; JOANNES J et al.1974; ANN. SCI. TEXT. BELGES; BELGE; DA. 1974; VOL. 22; NO 2; PP. 146-155; ABS. NEERL. ANGL. ALLEMArticle

NEUTROPENIA ASSOCIATED WITH EXCESS OF T CELL LYMPHOCYTESDELFORGE A; BRON D; STRYCKMANS P et al.1981; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1981; VOL. 49; NO 3; PP. 488-489; BIBL. 2 P.Article

CHEMOTHERAPEUTIC SENSITIVITY OF NORMAL AND LEUKEMIC HEMATOPOIETIC PROGENITOR CELLS TO N-(4-(9-ACRIDINYLAMINO)-3-METHOXYPHENYL)-METHANESULFONAMIDE, A NEW ANTICANCER AGENTSPIRO TE; SOCQUET M; DELFORGE A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 4; PP. 615-618; BIBL. 25 REF.Article

GRANULOCYTE-MACROPHAGE PROGENITOR CELL PRESERVATION AT 4^OCDELFORGE A; RONGE COLLARD E; STRYCKMANS P et al.1983; BRITISH JOURNAL OF HAEMATOLOGY; ISSN 0007-1048; GBR; DA. 1983; VOL. 53; NO 1; PP. 49-54; BIBL. 9 REF.Article

EFFECT OF 2 ANTI-ARRHYTHMIC DRUGS APRINDINE AND MOXAPRINDINE ON THE REPLICATION CAPACITY OF MURINE AND HUMAN HAEMOPOIETIC CELLSSTRYCKMANS PA; RONGE COLLARD E; DELFORGE A et al.1982; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1982; VOL. 29; NO 4; PP. 331-337; BIBL. 20 REF.Article

TREATMENT OF BRAIN GLIOMAS WITH HIGH DOSE OF CCNU AND AUTOLOGOUS BONE MARROW TRANSPLANTATIONHILDEBRAND J; BADJOU R; COLLARD RONGE E et al.1980; BIOMEDICINE; FRA; DA. 1980; VOL. 32; NO 2; PP. 71-75; ABS. FRE; BIBL. 14 REF.Article

CHIMIOTHERAPIE INTENSIVE SUIVIE D'AUTOGREFFE POUR LE TRAITEMENT DES LYMPHOMES MALINS REFRACTAIRES A LA CHIMIOTHERAPIE CLASSIQUE: REALISATION ET PROJETSSTRYCKMANS P; DEBUSSCHER L; DELFORGE A et al.1982; REV. MED. BRUX.; ISSN 0035-3639; BEL; DA. 1982; VOL. 3; NO 4; PP. 255-260; ABS. ENG; BIBL. 31 REF.Article

A CALCIUM-DEPENDENT PROTEIN ACTIVATOR OF GUANOSINE 3':5'-MONOPHOSPHATE PHOSPHODIESTERASE IN BOVINE AND RAT PANCREAS. ISOLATION, PROPERTIES AND LEVELS IN VIVO.VANDERMEERS A; VANDERMEERS PIRET MC; RATHE J et al.1977; EUROP. J. BIOCHEM.; GERM.; DA. 1977; VOL. 81; NO 2; PP. 379-386; BIBL. 30 REF.Article

Nécrose palatine par consommation de cocaïne = Palatal necrosis due to cocaine abuseMYON, L; DELFORGE, A; RAOUL, G et al.Revue de stomatologie et de chirurgie maxillo-faciale. 2010, Vol 111, Num 1, pp 32-35, issn 0035-1768, 4 p.Article

Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cellsLAGNEAUX, L; DELFORGE, A; SNOECK, R et al.Experimental hematology. 1994, Vol 22, Num 1, pp 26-30, issn 0301-472XArticle

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cellsLAGNEAUX, L; DELFORGE, A; BRON, D et al.Blood. 1998, Vol 91, Num 7, pp 2387-2396, issn 0006-4971Article

Leucémie à basophiles, évolution d'une leucémie myéloïde chronique. A propos d'un cas et revue de la littérature = Basophilic leukemia, evolution of a chronic myeloid leukemia. Case report and review of the litteratureLOSSIGNOL, D; BRON, D; DEBUSSCHER, L et al.Nouvelle revue française d'hématologie. 1987, Vol 29, Num 5, pp 307-310, issn 0029-4810Article

Prevention of CMV-induced myelosuppression by anti-CMV antibodies : an in vitro modelBRON, D; LAGNEAUX, L; DELFORGE, A et al.Experimental hematology. 1991, Vol 19, Num 2, pp 132-135, issn 0301-472X, 4 p.Article

Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factorsLAGNEAUX, L; DELFORGE, A; CARLIER, S et al.British journal of haematology. 2001, Vol 112, Num 2, pp 344-352, issn 0007-1048Article

Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitorsDELFORGE, A; VANDENPLAS, B; LAGNEAUX, L et al.European journal of haematology. 1990, Vol 44, Num 5, pp 307-311, issn 0902-4441, 5 p.Article

Immunothérapie adoptive par interleukine-2: premiers résultats d'une étude pilote chez 6 malades cancéreux = Adoptive immunotherapy by interleukine-2: preliminary results of a pilot study in 6 patients with cancerSCULIER, J. P; BRON, D; DELFORGE, A et al.La Presse médicale (1983). 1989, Vol 18, Num 23, pp 1155-1158, issn 0755-4982, 4 p.Article

Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV)BRON, D; DELFORGE, A; LAGNEAUX, L et al.Journal of immunological methods. 1990, Vol 130, Num 2, pp 209-216, issn 0022-1759, 8 p.Article

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding studyLEWALLE, P; TRIFFET, A; DELFORGE, A et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 1, pp 39-44, issn 0268-3369, 6 p.Article

Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cellsLAGNEAUX, L; MARIE, J.-P; DELFORGE, A et al.Experimental hematology. 1989, Vol 17, Num 7, pp 843-846, issn 0301-472XArticle

Differential sensitivity of normal marrow myeloid progenitor cells to mitoxantrone and bisantrene = Sensibilité différentielle des cellules myéloïdes progénitrices de la moelle normale à la mitoxantrone et au bisantrèneDODION, P; BRON, D; ROZENCWEIG, M et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1983, Vol 12, pp 29-38, issn 0146-0447Article

Imabalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infectionLAGNEAUX, L; DELFORGE, A; SNOECK, R et al.The Journal of infectious diseases. 1996, Vol 174, Num 5, pp 913-919, issn 0022-1899Article

Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cellsLAGNEAUX, L; DELFORGE, A; SNOECK, R et al.Blood. 1996, Vol 87, Num 1, pp 59-66, issn 0006-4971Article

Increased levels of myeloid progenitor cells in the blood of patients with metastatic invasion of the marrowDELFORGE, A; DE CALUWE, J. P; RONGE-COLLARD, E et al.Scandinavian journal of haematology. 1983, Vol 31, Num 3, pp 275-279, issn 0036-553XArticle

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumorsSTAHEL, R. A; SCULIER, J. P; JOST, L. M et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 6, pp 965-972, issn 0277-5379Article